Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -111.51% is 124% below its 5-year average of -49.86%, near the low end of its 5-year range (-111.51%–-14.64%).
55.83% below its 12-month average of -71.56%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -45.23%.
RETURN ON ASSETS (ROA)
-111.51%
RETURN ON ASSETS (ROA) AVG TTM
-71.56%
RETURN ON ASSETS (ROA) AVG 3Y
-64.13%
RETURN ON ASSETS (ROA) AVG 5Y
-49.86%
RETURN ON ASSETS (ROA) AVG 10Y
-65.17%
RETURN ON ASSETS (ROA) AVG 15Y
-50.92%
RETURN ON ASSETS (ROA) AVG 20Y
-44.12%
CURRENT VS TTM AVG
-55.83%
CURRENT VS 3Y AVG
-73.87%
CURRENT VS 5Y AVG
-123.64%
CURRENT VS 10Y AVG
-71.11%
CURRENT VS 15Y AVG
-118.99%
CURRENT VS 20Y AVG
-152.75%
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-245.61%
vs the sector median at left
Curis, Inc.
Market Cap
$1.46M
Return on Assets (ROA)
-111.51%
TTM Avg
-71.56%
3Y Avg
-64.13%
5Y Avg
-49.86%
Market Cap
$1.47M
Return on Assets (ROA)
-23.39%
TTM Avg
-29.27%
3Y Avg
-34.02%
5Y Avg
-43.63%
Market Cap
$1.49M
Return on Assets (ROA)
-36.88%
TTM Avg
-64.67%
3Y Avg
-76.84%
5Y Avg
-289.12%
Market Cap
$1.42M
Return on Assets (ROA)
-20.46%
TTM Avg
-67.47%
3Y Avg
-117.99%
5Y Avg
-101.96%
Market Cap
$1.52M
Return on Assets (ROA)
-148.13%
TTM Avg
-399.46%
3Y Avg
-266.31%
5Y Avg
-266.31%
Market Cap
$1.39M
Return on Assets (ROA)
-247.39%
TTM Avg
-97.35%
3Y Avg
-1378.80%
5Y Avg
-1078.71%
Market Cap
$1.34M
Return on Assets (ROA)
-196.18%
TTM Avg
-334.48%
3Y Avg
-197.38%
5Y Avg
-169.68%
Market Cap
$1.33M
Return on Assets (ROA)
-72.52%
TTM Avg
-80.61%
3Y Avg
-249.55%
5Y Avg
-240.26%
Market Cap
$1.32M
Return on Assets (ROA)
-96.27%
TTM Avg
-335.81%
3Y Avg
-263.87%
5Y Avg
-193.48%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Curis, Inc. (CRIS) | $1.46M | -111.51% | -71.56% | -64.13% | -49.86% |
| NEXGEL, Inc. (NXGL)vs › | $1.47M | -23.39% | -29.27% | -34.02% | -43.63% |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | -36.88% | -64.67% | -76.84% | -289.12% |
| INVO Fertility, Inc. (IVF)vs › | $1.42M | -20.46% | -67.47% | -117.99% | -101.96% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | -148.13% | -399.46% | -266.31% | -266.31% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.39M | -247.39% | -97.35% | -1378.80% | -1078.71% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.34M | -196.18% | -334.48% | -197.38% | -169.68% |
| NewcelX Ltd. (NCEL)vs › | $1.33M | -72.52% | -80.61% | -249.55% | -240.26% |
| Genprex, Inc. (GNPX)vs › | $1.32M | -96.27% | -335.81% | -263.87% | -193.48% |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | -75.13% | -57.43% | -49.05% | -61.98% |
ROA
-111.5%
ROE
-450.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -37.97% |
| 2024-12-31 | -105.15% |
| 2023-12-31 | -61.35% |
| 2022-12-31 | -52.07% |
| 2021-12-31 | -27.99% |
| 2020-12-31 | -14.64% |
| 2019-12-31 | -91.55% |
| 2018-12-31 | -87.18% |
| 2017-12-31 | -72.25% |
| 2016-12-31 | -104.60% |
| 2015-12-31 | -62.11% |
| 2014-12-31 | -29.91% |
| 2013-12-31 | -15.29% |
| 2012-12-31 | -23.46% |
| 2011-12-31 | -20.46% |
| 2010-12-31 | -8.76% |
| 2009-12-31 | -27.21% |
| 2008-12-31 | -30.32% |
| 2007-12-31 | -12.94% |
| 2006-12-31 | -16.89% |
| 2005-12-31 | -24.39% |
| 2004-12-31 | -20.56% |
| 2003-12-31 | -20.85% |
| 2002-12-31 | -131.83% |
| 2001-12-31 | -56.55% |
| 2000-12-31 | -191.78% |
| 1999-12-31 | -41.91% |
